Влияние антидепрессантов азафена, инказана и пиразидола на гликемическое действие адреналина, как показатель их лекарственной безопасности (экспериментальное исследование)
Диссертация
Проведенные нами исследования показали, что азафен, инказан и пиразидол при длительном введении собакам и крысам в дозах, превышающих терапевтические в 10−50 раз, не изменяют функции печени, но достоверно снижают содержание иммунореактивного инсулина в крови. В отношении влияния на функцию печени антидепрессанты — ингибиторы МАО существенно отличаются от инказана и пиразидола и, как мы уже… Читать ещё >
Список литературы
- Авакян О.М.2. Абдулов Н. А., Майеов Н.И.
- Андреева Н.И., • Глушков Р.Г., Машковский М. Д,
- Фармакологическая регуляция высвобождения и захвата норадреналина. Изд-во Ш Армянской ССР, 1973.
- Сравнительная оценка влияния антидепрессантов различных групп на обратный захват медиаторов синап-тосомами мозга крыс. 1У Всесоюзный сшлпозиум по целенаправленному изысканию физиологически активных веществ. Рига, 1981, 58.
- Новый антидепрессант инказан. Хим.-фарм.я., 1979, JM, III-II4.
- Андреева Н.И., Машковский М.Д.
- Васильевых Л.Г., Глушков Р. Г., Горкин В. З., Каган Н. И. и др.
- Гольденберг М. А. Короленко Ц.П., Баженова Г.А.7. Горкин В.З.8. Горкин В.З.
- Горкин В.З., Татьяненко л.В.
- Трубицына Т.К., Машковский М.Д.
- Фармакологическое исследование нового отечественного антидепрессанта инказана.
- Фармакол. и токсикол., 1980, 152, 133−137.
- Кинетика ингибирования митохонд-риальной моноаминооксидазы инка-заном.
- Хим.-фарм.ж., 1979, № 7, 20−24.
- Некоторые показатели углеводного обмена при тофраниловом «психозе» у животных.
- В кн.: Тофраниловый психоз в эксперименте и клинике. Труды Новосибирского мед. ин-та., 1965, 43, 73−75.
- Аминооксидазы и их значение в медицине .1. М. Медицина, 1981, с. 8.
- Достижения в изучении моноамино-оксидаз, ингибиторов МО и их значение для изыскания новых лекарственных средств. Хим.-фарм.ж., 1977, II, Ж, 6−13.
- Кривченкова P.O. Романова Л.А.
- Кутчак С.И., Шарова С. А., Егорова Е.Ф.
- Кяэр-Кангисепп Э, Тээсалу С., Вааса И., Хинрикус Т.17. Лангнер М.А.18. Лангнер М. А, 19. Лапин И.II.
- Об особенностях адреносенсибилизирующего действия трициклическихантидепрессантов.
- Фармакол. и токсикол., 1974, JS6,677.680.
- Особенности пресинаптического действия антидепрессантов разного химического строения. 1У Всесоюзный симпозиум по целенаправленному изысканию физиологически активных веществ. Рига, 1981, 14.
- Аденилциклаза и фосфодиэстераза аденозин-3,5-монофосйата: природа, свойства, регуляция. Вопр. мед. химии, 1976, 12, 151−159.
- Практикум по эндокринологии. Основные методики экспериментальио-эндокрин ологиче ских ис следований. М., 1968, 103−105.
- Влияние некоторых трициклических антидепрессантов на активность моноаминоокеидазы печени, мозга и сердца крыс.
- Фармакол. и токсикол., 1966, J83, 313−316.
- Токсикологическое исследование азафена.
- Фармакол. и токсикол., 1971, $ 3, 291−292.
- Гипергликемизирующее действие серотонина.уч.зап.Тартус.ун-та., 1974, вып.319, 93−98.
- Патопсихологическая характеристика состояний при сахарном диабете. В кн.: Гормоны и мозг, п/р А. И. Белкина. Московский НИИ психиатрии. М., 1979,86,73−81.
- Значение психотерапии в комплексном лечении сахарного диабета. Там же, 62−72.
- Антидепрессанты группы имипрамина. В кн.: Антидепрессанты и лечение депрессивных состояний. Л., 1966, т.34, 31−51.20. Лапин И.П.• Хаунина Р. А., Щелкунов Е.А.
- Лукомская И.О.,. Городецкий В.К.22. Машковский М.Д.23. Машковский М.Д.• Андреева Н.й.
- Машковский М.Д., Горкин В.3., Андреева Н. И., Веревкина И. В. и др,
- Машковский М.Д., Горкин В. З., Веревкина И. В., Аснина В. В. и др.26.- Машковский М. Д., Гринев Н. А., Алтухова Л. В., Шведов В. И. и др.
- Машковский М.Д., Середенин С. В., Андреева Н.И.-, Бледнов Ю. А. И др.
- Машковский М. Д, Полежаева А.И.29. Ньюсхолм Э., Старт К.30. Паэсалу Э. И. • Тарве У.С.31. Петрунышна A.M.
- Влияние тофранила на эффекты адреналина, норадреналина и фенамина. Журн.невропатол. и психиатр., 1962, 2, 183−189.
- Применение микроцида (глюкозоокси-дазы) для определения"глюкозы крови в норме и при диабете. Биохимия, 1961, 26, 3, 477−482.
- Лекарственные средства. М., Медицина, 1977, 99.
- Экспериментальное изучение, психотропного действия пиразидола. Фармакол. и токсикол., 1975, I,
- Исследование механизма действия нового антидепрессанта пиразидола. Фармакол и токсикол., 1975, JI5, 531−536.
- Избирательное ингибирование пиразидолом моноаминооксидазы типа А. Бюлл. экспер. биол., 1981, 112, I69-I7I.
- Новый отечественный антидепрессивный препарат пиразидол. Хим.-фарм.ж., 1974, J83, 60−63.
- Распределение по органам и выведение из организма крыс пиразидола14с.
- В сб.: Фармакокинетика и метаболизм лекарственных препаратов. М., 1978, 7, 86−91.
- Фармакологические свойства нового антидепрессивного препарата азафена. Фармакол. и токсикол., 1969, 6, 656−662.
- Регуляция метаболизма. Изд-во «top». М., 1977, III-I29.
- Влияние антидепрессантов тразодона и имипрамина на активность а, К-АТФ-азы, Са-АТФ-азы и актомиози-ноподобнои АТФ-азы мозга. Тарту. 1978, 81−84.
- Практическая биохимия. Медгиз. Л., 1961.32. Полежаева А.И.33. Полежаева А. И.,• • Берт оград ова О.П., Багреева М.Р.34. Покровский А.А.35. Прихожан В.М.36. Протасова Т.Н.37. Розен В.Б.
- Романова Л.А., Синюхин В. Н., Полежаева А. И. Горкин В.З.39. Самсонова М.Л.
- Селезнев Ю.М. Мартынов А.В.41. Синюхин В.Н.42. Твердова Е.Б.
- Терехина А.И., Каверина Л. П., Трицина Т. Н., Рудзит Э.А.
- К фармакологии антидеирессантов трициклической структуры. Фармакол. и токсикол., 1967, Js2, 243−249.
- Новый антидепрессивный препарат аза&ен.хим.-фарм.ж., 1970, Ш, 59−62.
- Биохимические методы исследования в клинике. М., 1974.
- Поражение нервной системы при сахарном диабете. М., Медицина, 1981, 295.
- Гормональная регуляция активности ферментов. Медицина, 1975, 81−83.
- Основы эндокринологии. ' М., Высш.шк., 1980, 298−304.
- О влиянии производных диазафенокса-зина на моноаминооксидазную активность.
- Фармакол. и токсикол., 1974, М, 391−393.
- Торможение триптофанпирролазной активности печени крыс при введении имипрамина и других антидепрессантов.
- Вопр.мед.химии, 1973, $ 2,148−151.
- Кортикостероиды и активация адреналином гликогенфосфорилазы в сердечной ткани.
- Проб.эндокринологии, 1980, ЖЕ, 64−68.
- Метаболизм и влияние на обмен норадреналина нового антидепрессанта азафена. Диссертация. М., 1974.
- Побочный гликемический эффект у больных в результате лечения нейролептиками.
- Журн.невропатол. и психиатр., 1976,76 1Й, 450−452.
- Влияние карбоната лития на почечную экскрецию натрия и калия у интактных и адреналэктомированных крыс.
- Фармакол. и токсикол., 1979, И, 23−25. .44. Хроника ВОЗ.
- Яшунский В.Г., Машковский М. Д., Горкин В. З., Холодов Л. Е. и др.
- Abdullah М., Fleming J., Taulor P., Wheilan W.47• Albano J., Вгош В., Ekins R.
- Anderson H., Kristiansen Б.49. Ahlquist R.P.50. Arneson G.51 .Arieff A., Adams J.52. Asberg Ы.53″ Askei J. 54. Axelrod J.
- Серия технических докладов ВОЗ. 1981, В 646.
- Синтез, Фармакологические свойства и влияние на активность моноамино-оксидазы некоторых сиднонишнов. Фармакол. и токсикол., 1970, В 3, 297−302.
- Substrate specificity of the amylo-glucosidase of Aspargillus niger. Bio-chem. J., 1963, 89, 1, 35−38.
- The effect of increased К concentration and serotonin on cyclic AMP and corticosterone output by dispersed adrenal zona glomerulosa cells.
- Endocrinology, 1973, 58, xi.
- Tofranil treatment of endogenous depression.
- Acta Psychiatr. Neurol. Scand., 1959, 34, 387−397.
- Present state of alpha and beta-adrenergic drugs. The adrenergic receptor.
- Amer. Heart. J., 1976, 92, 5, 661−664.
- Phenothiazine derivatives and glucose metabolism. J. Neuropsychiat., 1964, 5, 181−185.
- Treatment of recurrent mental depression with innipramine. Illinois med. J., 1961, 120, 245 248.
- Ballard P. Baxter J •, Higgins S.58. Badawy A., Ivlyrddln E.59. Ban (Г., 1. St.-Jean A.
- Baran L., Mao J-" Ragoz L., Skuza G.
- Baum 0?., Shropshire A. Rowls G., Goukman M.62. Bickel Ы.63. Blackwell B. Marley E.
- Bloom S., Edwards A., Yaughan H.
- Borga 0., Azarnoff D., Porshell G.
- Bogdanski D" Tissani A., Brodie B.
- Central anticholinergic activity and tricyclic antidepressant efficacy. International Drag Therapy newsletter, 1975 (a), 10, 21.
- A controlled trial of imipramine in treatment of depressive states. Brit. Med. J., 1959, 2, 1052−1055.
- The effect of phenothiazines on the electrocardiogram.
- J.Can.Med.Assoc., 1964, 91, 537−540.
- On the central antiserotonin action of trazodone.
- Pol. J. Pharraac.Pharm., 1979, 31, 25−35.
- Antidepressants in cardiac conduction-1.rindole and Imipramine.
- Eur. J. Pharm., 1971, 13, 287−291.
- The role of the sympathetic innervation in the control of plasma glucagon concentrations in the calf. J. Phisiol. (bond), 1973, 233, 457.
- Plasma protein binoling of tricyclic antidepressants in man. Biochem. Pharmacol., 1969, 18, JS 9, 2135- 2143.
- The effects of inorganic ions on uptake, storage and metabolism of biogenic amines in nerve endings.
- Psychopharmacology: A Review of Progres 1957−1967, Efron D.,(ed.), U.S. Govt. Printing Office, Washington, D.O., 1968, pp. 17−26.
- Briant R., Reid J., Dollery G.
- Briley LI., Langer S., Raisman R., Sette M.
- Brodie B., Pletscher A, Shore P.70. Brody Т., McNeill•
- Brown Т., Barker G., Dunlop M., ¦Longhman P.
- Brunzell J., Robertson R., Lemer R. et al.73. Bruss M., Black A.
- Burckhardt X)., Fleischhauer H. Muller V., Naubauer H.75″ Campbell C., Murphy D., Walker M., Lovenberg V/, Robinson D.76. Campbell J., Todrick A.
- Campbell J., Shiling D., Lipper S., Slater S., Murphy D.1.teraction between clonidine anddesipramine in man.
- Br. Med. J., 1973, 7, 522−523.r>1.calisation of H^-imipramine binding sites on serotonin nerve terminals. Brit. J. Pharmacol., 1981, 74, 1, 217.
- Possible role of serotonin in brain function and reserpine action. J. Pharmacol, exp. Ther., 1956, 116, 9−10.
- Adrenergic receptors for metabolic responses in skeletal and smooth muscles.
- Fed. Proc., 1970, 29, J6 4, 1375−1378.
- The use of sodium bicarbonate in the treatment of tricyclic antidepressant induced arrhytmias. Anesth. Intensive Care, 1973, 1 (3), 203 -207.
- Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests.
- J. Clin. Endocr., 1976, 42, 222 -225.
- Enzymatic microdetermination glucogen. Anal. Biochem. Rhizopus., 1978, 84, 1, 309−312.
- Beitrag zur wirkung tri- und tetra-zyklischer antidepressiva auf herz und kreislauf.
- Schweizerische Medizinische Wochen-schrift, 106, 1896−1903 f 1976.
- Monoamine oxidase inhibitors (MAO) increase rat brain aromatic amino acid decarboxylase activity. Brit. J. Clin. Pharm., 1980, 9, № 4, 431−432.
- Plasma protein binding of tricyclic antidepressive drugs. J. Pharm. and Pharmacol., 1970, 22, |5 3, 226−227.
- A biochemical measure of monoamine oxidase type A and B inhibitor effects in man.
- J. Psychiat. Res., 1979, 15, № 2, 17−84.78. Cairncross К., Gershon S.
- Carlson L., Butcher R., Micheli H.
- Carlsson A. Hillarp IT.,. Waldeck B.
- Carlsson A., Lindgvist M. Magnusson I.82. Carlsson A., Lindovist M.
- Oarr P., Smith S., Pogson C.
- Chessin M., Dubnick B., Leeson G., Scott C.
- Chodera A., Bobkiewier T. Czekabski S.
- Clement-Cormier Y. Kebabian J., Petzold 6., Greengard P.87. Clark J.88, Clement A., Benazon D.
- A pharmacological bans for the cardiovascular complications of imipramine medication. Ivied. J. Aust., 1962, 2, 372−375.
- Pat mobilising lipolysis and levels of cyclic AMP in human and dog adipose tissue.
- Acta Med Scand., 1970, 187, 525−528.
- Analysis of Mg+± ATP dependent storage mechanism in the amine granules of the adrenal medulla. Acta Physiol. Scandinav., 1963, 59, (suppl. 215).3,4-Dihydroxyphenylalanine and 5-Hydrosytryptophan as reserpine antagonists.1. Nature, 1957, 180, 1200.
- Effects of antidepressant agents onmonoamine synthesis.
- Sym. Med. Hoechst, 1977, 13, 95−105.
- Monoamine oxidase inhibitors and liver metabolism: studies with isolated rat hepatocytes. Biochem. Pharmacol., 1980, 29, J-2 8, 1103−1108.
- Biochemical and pharmacological studies of В-phenylethylhydrazine and selected related compounds. Ann. Ы. V. Acad. Sci., 1959, 80, 597−608.
- The role of cyclic adenosine 3'5'топо-phosphate (c.AMP) ih the mechanism of action of tricyclic antidepressants. Arch, immunol. et ther. Exp., 1977, 25, 2, 163−168.
- Dopamine-sensitive adanylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc. Hat. Acad. Sci., USA, 1974, 71, JM, 113−117.
- Side-effects of tranylcypromine. Lancet, 1961, (-18 mars), 618−619.
- Reactions to other drugs in patients taking monoamine-oxidase inhibitors. Lancet, 1962, (28 juli), 197−198.
- Clinton В. Ronald D., Smith.90w Connel P.
- Cooper A., Magnus R., Rose M.$ 2. Dally P.93. Davies E.94• Davila J•, Gonzalez P, 95″ Delini-Stula A.
- Desiles M., Puech A., Rips R.97. De Wild D., Weijnen J.
- Di Hascio A. Heninger G., Klerman G.
- Dingel J., Sulser F., Gillette J.100. Dipple P., Williams D.101. Dorrell W.
- Blood sugar responses to epinephrine in the dog in the presence of dual adrenergic «blockade. Eur. J. Pharmacol., 1977, 42, 1−9.
- Central nervous system stimulant and antidepressant drugs. In Side-Effects of Drugs, vol., 6, L, Meyler L. and Herxheimer (eds), Excerpta Medica. Amsterdam, 1968, 1−50.
- Hypertensive syndrome with tranyley-promine medication. Lancet, 1964, 1, 524−527.
- Fatal reaction associated with tranylcypromine and methylamphetamine. Lancet, 1962, (9juni), 1235−1236.
- Combining the antidepressant drugs. Lancet, 1963, (12 oct), 781−782.
- Potenciacion de lainsulina por algunos antidepresivos. Su efecto sobre la glucogeno sintetase hepatica. Arch. ITeurobiol., 1977, 40, $ 2, 123 128.
- Brit. J. Pharm., 1980, 69, JS 2, 163−166,
- Pituitery, adrenal and the brain. Prog. Brain. Res., 1970, 12, 1−357.
- Psychopharmacology of imipramine and desipramine: a comparative study of their effects in normal males. Psychopharmacologia, 1964, 5, 361−371″ Species differences in the metabolism of imipramine and desmethylimipramine (BMI).
- J. Pharmacol, exp. Ther., 1964, 143, 14−22.
- Hepatites caused by the newer amine-oxidase -inhibiting drugs. Lancet, 1961, (30 decern), 1459.
- Tranylcypromine and intracranial bleeding.1.ncet, 1963, (10 aug), 300−301.102. Douglas W, 5. Iiydroxyt ryptanine •
- The Pharmacological Basis of -Therapeutics, 5 th edition, 1975, ed., Goodman L., Gilman A., 612−622,103. Dulin II., Soret M.
- Chemically and hormonally induced diabetes.
- The diabetic pancreas, ed. Volk В., Wellmann K.104. Erspamer V.
- Exton J., Friedmann IT. Wong E., Brineaux J., Corbin J., Park C.106. Fargharson S, 107. Fasoli R., Glauser P.108. Pekete M., Maesek J.109. Piscke C., Subbarow J, 110. Forika M., Forika G.111. Pourson J., Chuoine R.112. Prandsen E,
- Friedman E. Pung F., Gershon S.
- Recent research in the field of, 5-hydroxytryptamine and related indolealkylamines.
- Fortschr. Arzneimittel-Sorch., 1961, Bd.3, 236−238.1.teraction of Glucocorticoids with Clucagon and Epinephrine in the Control of Clueoneogenesis and Clycogenolysis in Liver and1 Lipolisis in Adipose Tissue.
- J. Biol. Chem., 1972, 247, 3579−3588.
- Poisoning by tricyclic drugs. Brit. Med. J., 1972, 1, 378−381.
- Cardiac arrytmias and ECD abnormalities in tricyclic antidepressant overdose. ~ Clin. Toxicol., 1981, 18, 2, 155−163.
- The effect of imipramine cocaine and neostigmine on hyperglycaemic response to noradrenaline and adrenaline. J. Pharm. Pharmacol., 1968, 20, 4, 327−328.
- The colorimetric determination of phosphorus.
- J. Biol. Chem., 1925, 66, 375−377.
- Efectul dozelor mari de imipramina asupra repartiei ionilor der К si Na in princimlele ograne. Neurol. Psihiat. Neurochir., 1974, 22, 4, 281−284.
- ECG changes in fatal imipramine (Tofranil) intoxication. Pediatrics, 1971, 44, 777−779.
- Toxic amblyopia during antidepressant treatment with pheniprazine (catran). Acta Psychiat. Scand., 1962,38, 1−14.
- Antidepressant drugs uptake in different brain regions.
- Europen. J. Pharmac., 1977, 42, 47−51.114. Frohman L., Bernardis L.
- Frost' J., Egan G., Middlefell R.116. Halaris A., Karbowski M.117. Halas E.118. Hers H.
- Hers H., Stalmans W. De Wulf H., Laloux M., Hue L.120. Hess M., Shanfeld J.121. Hess S., 1. Weissbach H., Redfield B.
- Holdsworth C.: Atkinson M., Goldie W.
- Horwitz D., Goldberg L., Sjoerdsma A.124″ Howarth E.
- Hjalmarson A. Beviz A., Jsaksson 0.
- Effect of hypothalamic stimulation on plasma glucose, insulin and glucagon levels.
- Amer. J. Physiol., 1971, 221, 1596−16 011. New drugs for depression.
- Brit. Med. J., 1960, (13 feb), 503.
- Effects of tricyclic antidepressants on acetylcholine turnover and choline uptake.
- Psychopharmacol. Bull., 1979, 15, 2, 48−49.
- Further data to the clinical effects of nialamide.
- Am. J. Psychiat., 1963, 119, 785−786.
- Glycogen Storage Disease. Advanced metabolic. Dis., 1964, VT, 1−44.
- The control of glucogen metabolism in the liver.
- Ergebnisse der Experiment. Medizin., 1974, 18, 77−88.
- Sensitization of the hearts to the biochemical effects of epinephrine produced by adrenal cortical steroids. Biochem. Pharmacol., 1963, 12, suppl., 119.
- The relationship between iproniazid metabolism and the duration of its effect on monoamine oxydase. J. Pharmacol, exp. Ther., 1958. 124, 189−193.
- Hepatitis caused by the newer amine-oxidase-inhibiting drugs. Lancet, 1961, (16 sept), 621−623.1.creased blood pressure responses todopamine and norepinephrine.
- J. Lab. Clin. Med., 1960, 56, 747−753.
- Possible synergistic effects of the new thymoleptics in connection with poisoning.
- J. Ment. Sci., 1961, 107, 100−103.
- Metabolism of the heart with reference to beta blockade. Int.. Klin. Pharmakol. Ther und Toxicol., 1969, № 3, 21−28.126. Huang M., Daly J.127. Gaultieri C., Powell S.
- Glasser H., Krieglstein J129. Gilbert J., Wyllie M.130. Gillespie L.131. Givant J., Sulman P.
- Glassraan A., Hurwie M., Kanzler M.
- Goldberg L., Hov/itz D., Sjoerdsma A.134. Goldberg L., Sjoerdsma A.
- Golds P., Przyslo P., Strange P.
- Accumulation of cyclic adenosine monophosphate in incubated slices of brainb 1S SU. 6
- J. Med! Chem., 1972, 15, 458−462.
- Psychoactive drug internetions. J. Clin. Psychiat., 1978, 39, й 9.
- Die Eiweissbindung einiger Psychophar-maka mit tricyclischem Ringsystem in Abhangigkeit von ihrer chemischen Konstitution.
- Pharmacol., 1970, 265, JS 4, 321−334.
- The relationship between nerve terminal adenosine triphosphatases and neurotrans mitter release: as determined by the us? of antidepressant and other CHS-active drugs.
- Brit. J. Pharm., 1980, 69, 2, 215−225.
- Clinical pharmacology of newer antihypertensive agents, monoamine oxidase and decarboxylase inhibitors, brety-lium tosylate, and guanethidine. Ann. U.Y. Acad. Sci., 1960, 88, 10 111 020.
- Endocrine effects of psychotherapeutic drugs.
- Psychotherapeutic drugs. Part I, ed. Usdin S., Forrest J., Marsel Dekker, U-Y, 1976, 387−435.1.ipramine steady-state studies and plasma binding.
- Proceedings of the Third International Simposium on Phenothiazines and Structurally Related Compounds, Raven Press, Itf-Y, 1974, 457−463.
- Attenuation of cardiovascular responses to exercise as a possible basis for effectiveness of monoamine oxidase inhibitors in angina pectoris. J. Pharmacol. Exp. Ther., 1962, 137, 39−46.
- Effects of several monoamineoxidase inhibitors on the cardiovascular actins of naturally occurring amines in the dog. J. Pharmacol, exp. Ther., 1959, 127, 212−218.
- The binding of some antidepressant drugs to brain muscaric acetylcholine receptors.
- Brit. J. Pham., 1980, 68, В 3, 541−549.136. Goldstein D.: Curnow R.
- Gomoll A., Byrne J•, Deitchman R.
- Goodlet J., Mireyless S., Sugrue M.
- Goodsell E., Stein H., Wenzke K.140. Gram Lars141. Greef K., Wagner J.142. Greydanus D., Hofman A.143. Idestrom 0., Kalian E.
- Irvine R., Grove P., Toseland P., Trounce R.145. Iversen L.
- Javaid J., Perel J., Davis J.147. Jefferson J.
- Effect of starvation on hepatic glycogen metabolism and glucose homeostasis.
- Metabolism, 1978, 27, 3, 315−323.
- Hemodynamic and cardiac actions of trazodone and imipramine in the anesthetized dog.1.fe Sci., 1979, 24, № 20, 1841−1848.
- Effect of mianserin, a new antidepressant on the in vitro and vivo uptake of monoamines.
- Brit. J. Pharm., 1977, 61, № 2, 307 313.
- Substituted theophyllins. In vitro inhibition of 3'5f-cyclic adenosine monophosphate phosphodiesterase and pharmacological spectrum in mice. J. Med. Chem., 1971, 14, 1202−1205.
- Factors influencing the metabolism oftricyclic antidepressants.
- Dan. Med. Bull., 1977, 24, В 3, 81−89.
- Cardiodepressive und lokalanaesthetische
- Wirkungen der Thymoleptica.
- Arzneim. Forsch., 1969, 19, 1662−1664.
- Psychological factors in diabetes mellitus.
- Ann. J. Dis.Child., 1979, 133, 10 611 066.1. Pheniprazine treatment.
- Acta psychiat. scandinav., 1961, № 37,suppl) 160, 1−17.
- The effect of age on the hydroxylationof amylobarbLtone sodium in man.
- Br. J. Clin. Pharmacol., 1974, 1, 41−44.
- The uptake and storage of noradrenaline in sympathetic nerves. Cambridge, University Press, 1967, 120.1.hibition of biogenic amines uptake by imipramine, desipramine, 20H-imi-pramine and 20H-desipramine in rat1. T) •1.fe Sci., 1979, 24, № 1, 21−28.
- A review of the cardiovascular effects and toxicity of tricyclic antidepressants.
- Psychosomatic Medicine, 1975, 37, 160 163.148. Jones 0., 1. Bethesola M.149. Jones R., Roberts M.150, Joost H., Poser W., Panbou U.
- Kanarek S., Thomson P., Sevin S.152. Kaplan S., Mass J.153. Kety S.154. Khazen K.,
- Mishkinsky J. Ben-David M., Sulman P.155″ Kocur J., 1. Jurkowski A., Kedziora J.156. Kopin J., Axelrod J.157. Krosnick A.158. Kuhn R.
- Landmark K., Glomstein A. Qye J.
- Toxic Amblyopia caused by Pheniprasinehydrochloride (JB-516, Catron).
- Arch, of Ophthalmology, 1961, 66, 55-©.
- The management of imipramine intoxication in children.
- S. Afr. Med. J., 1973, 47, 19, 835−838.
- Use of imipramine in diabeticss effects on glycosuria and blood sugar levels. J. Amer. Med. Ass., 1960, 174, 511−517.
- Biochemical Theories of Schizophrenia, Science, 1959, 129, 1528, 1590.1.ctogenic effect of phenothiazine-like drugs.
- Arch. Int. Pharmacodyn., 1968, 174, 428−441.
- The influence of 5-hydroxytryptamine and some B-adrenolytic compounds on adenylylcyclase in rabbit brain in vitrc Pol. J. Pharmacol. Pharm., 1975, 27, suppl 113−117.
- The role of- monoamine oxidase in the release-and. metabolism of norepinephrine. Ann. N. Y. Acad. Sci., 1963, 107,848.855.
- Treatment of vascular complications ofdiabetes mellitus.
- Med. Treatm., 1967, 4, 85−108.
- The treatment of depressive states with G22355 (imipramine hydrochloride). Ann. J. Psychiat., 1958, 115, 459−464.
- The effect of thioridazine and promazine on the isolated contracting rat fee heart.
- Acta Pharmacol. Toxicol., 1969, 27, 173−182.160. Langer S.161″ Laroche M., Brodie B.162. Lebovitz H., Feldman J.163. Lechat P., 1. Auclaier M., Adolphe M.
- Lee W., Shin Y., Shideman F.165. Levine R., Sjoerdsma A.166. Lingiaerde 0,167. Lingioerbe 0,168. Lippmann Y/., Pugsley T.
- Longnecker D, Wold J., Fischer L.170. Logan J., 0'Donovan D.
- Specific tricyclic antidepressant binding sites in brain and platelets. Acta Pharmacol, et Toxicol., 1981, 40 suppl 1, 10−11.1.ck of relationship between inhibition of monoamineoxidase and potentiation of hexobarbital hypnosis.
- J. Pharmacol. Exp.Ther., 1960, 130, 133 137.
- Pancreatic biogenic amines and insulin secretion in health and desease. Fedn. Proc. Fedn Am. Soes. Exp. Biol., 1973, 32, 1797−1802.
- Effect of imipramine on cultured rat heart cells.
- Toxicol.and Appl. Pharmacol., 1974, 27, }'o 2, 336−341.
- Cardiac activities of several monoamine oxidase inhibitors. J. Pharmacol. Exp. Ther., 1961, 133, 180−185.
- Estimation of monoamine oxidase activity in man techniques and applications. Ann. IT.Y. Acad. Sci., 1963, 107, 966−974.1.hibitory effect of clomipramine and related drugs serotonin uptake in platelets more complicated than previously thought.
- Psychopharmacology, 1979, 61, }? 3, 245−249.1.hibition of platelet uptake of serotonin in plasma from patients treated with clomipramine and amitriptyline. Eur. J. Clin.Pharmacol., 1979, 15, lb 5, 335−340.
- Pirandamine, a relatively selective 5-hydroxytryptamine uptake inhibitor. Pharmacol. Res. Communs., 1976, 8, $ 4, 387−405.
- Ultrastructural study in Beta cells of pancreatic islets from cyproheptadine-treated rats.
- Diabetes, 1972, 21, 71−79.
- Miller Т., Ext on J •, Park C.
- Moratinos J., Rotter D., Ellis S.
- Moccetti Т., Lichtlen P., Gasaccia M., Halter J., 1,1 ohr P.
- Moir D., Cornwell W., Dingwall-Fordyc e Crooks J.179. Mosbech J.180. Moser P., Wyllie M.
- Mount30V C, Roth M., Carside R., Leitch J.182. Mitchell J, Oates J.
- Monoamines in the pancreatic islets of the mouse.
- Diabetologia, 1971, 7, 414−417.
- Poisoning with tricylic antidepressant drugs.
- Clin. Toxicol., 1977, 10,№ 2, 149−158.
- The effects of phenelzine on serotonin, noradrenaline and monoamine oxydase in the rat.
- Canad. J. Physiol. Pharmacol., 1964, 42, 33−39.1.teractions between catecholamines, 5-hydroxytryptamine and TSH on the secretion of thyroid hormone. Endocrinology, 1972, 90, 188−193.
- A Block in Epinephrine-induced 'jplycoge-nolysis in Hearts from Adrenal-ectomized rats.
- J. Biol. Chem., 1971, 246, 3672−3678.
- The influence of propranolol on catechol-amine-induced changes in carbohydrate metabolism in the rabbit. Eur. J. Pharmacol., 1975, 32, J5 2, 186−199.
- Tossicita cardiaca degli antidepressivi „Ь z*iLc iclici •
- G. Ital. Cardiol., 1972, 2, IS 3, 442−451.
- Cardiotoxicity of amitriptyline. Lancet, 1972, 7777, 561−564. J.,
- EKG changes under Tofranil treatment. Nord. Psykiatr. Tidsskr., 1960, 14, 326.
- Assessment of neurotransmitter uptake in vivo.
- Brit. J. Pharmacol., 1981, 72, 3, 488−489.
- A Clinical Trial of Phenelzine in Anxiety
- Depressive and Phobic Neuroses.
- Brit. J. Psychiat., 1977, 131, 486−492.
- Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs, J. Pharmacol Exp. Ther., 1970, 172, 100 107.183. Kitra Ch., Guha S.
- Muhbachova E., Chan Peter S., Ellis S.
- Muller 0., Goodman II., Bellet S.186, Hakamura Mitsutakas Pukushima Hideaki.187. Nagy A., 1. Pertorini R.188. Hatoff J.189. Hemeс J.190. Newton IT., Hornbrook K“
- Hies A., Robinson D. Davi s J., Ravaris L.192. Palatini P.193. Petit J., Biggs J.
- Pletscher A. Gey K., Zeller P.
- Serotonin oxidation by type В MAO of rat brain.
- Biochem. Pharmacol., 1980, 29, 13 9, 1213−1216.
- Quantitative studies of glucose release from rabbit liver slices induced by catecholamines and their antagonism by propranolol and phentolamine. J. Pharmacol, and Exp. Ther., 1972, 182, 3, 370−377.
- The hypotensive effect of imipramine hydrochloride in patients with cardiovascular disease.
- Clin. Pharmacol. Ther., 1961, 2, 300.
- The effect of tricyclic antidepressants and neuroleptics on the peripheral and central action of norepinephrine in reserpine-treated mice. Eur. J. Pharmacol., 1976, 38, IS 2, 343 348.
- Uber die Klinische Anwendung des Melipramins (Imipramine). Ideggyog. Szle., 1963, 14, 120−126.
- Chese and monoamine oxidase inhibitors. Interaction in anasthetised cats. Lancet, 1964, (7 march), 532−533.
- Cardiotoxic effects of tricyclic antipsychotics.
- Toxicol. Exp., 1973, 4−5, 224−231.
- Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase.
- J.Pharmac.Exp.Ther., 1972,181, 479−488. Changes in monoamine oxidase with aging. In Psychopharmocology and Aging, eds Eisdorfer C., Fann V/., Plenum. H.Y., 1973, 41−54.
- The interaction of tricyclic antipsychotics with (Ha+ K+)-АТРаЛе. Gen. Pharmacol., 1978, 9, В 4, 215−220.
- Tricyclic antidepressant over doses inadolescent patients.
- Pediatrics, 1977, 59, 2, 283−287.1. Monoaminoxydase-Hemmer•
- Progr. in Drug Res., 1960, 2, 417−590.195. Porte D., Robertson.196.Potter W., 1. Muscetola G., Goodwin P.
- Prange A, Wilson J., Lipton M., Rabon A. Mayo, McClae Thomas K. Knox Angelina E.
- Proost C., Carton H., De Wulf H.199. Opitz K, 200. Osborne D.
- Quickel J., Peldman J., Lebovitz H.
- Raisman R., Briley M., Danger S.203. Rasbogi R.
- Rasmussen E., Kristiansen P"205. Reitman S., Prankel S.
- Richardson B. McDaniel M., Lacy P., Lois St.
- Control of insulin secretion by catecholamines, stress and sympathetic nervous system.
- Pedn, Proc. Fedn. Am. Socs exp. Biol., 1973, 32, 1792−1796.
- Binding of imipramine to plasma protein and brain tissue: relationship to CSP tricyclic levels in man. Psychopharmacology, 1979, 63, 2, 187 192.
- Use of thyroid hormone to accelerate the action of imipramine. Psychosomatics, 1970, 11, 5, 442−444.
- The a-adrenergic control of rabbit liver glycogenolysis.
- Biochem.Pharmacol., 1979, 28, 14,21 872 191.
- Wirkungen psychotroper Substanzen auf den Stoffwechsel.
- Arzneimittel-Porschung., 1962, 12, 525 531.
- The alpha adrenergic receptor mediated increase in guinea-pig liver glycogeno-lysis.
- Biochem. Pharmacol., 1978, 27, 1315−1320.1.hibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology, 1971, 89, 1295−1301″
- High-affinity нз -imipramine binding in rat cerebral cortex.
- Eur. J. Pharmacol., 1979, 54, 3, 307−308.
- Evidence for the role on adrenocortical hormones in the regulation of noradre-nalins and dopamins metabolism in certain brain areas.
- Br. J. Pharmac., 1978, 62, 131−136.
- ECG changes during amitriptyline treatment.
- Am. J. Psychiatr., 1963, 119, 781−782.
- A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer. J. Clin. Pathol., (Baltimore), 1957, 28, 56.
- Effects of cyproheptadine on insulin secretion by isolated perifused rat islets. Diabetes, 1975, 24, 836−841.
- Robertson R. Halter J., Porte J.208. Robinson S. Barker E.209. Rohner Th., Sanford E.210. Romer J., Bickel M.
- Rosenblatt J., Tallman J., Pert A., Bunney V/.212. Van Rossum J.213. Sabelli H., Sinay J.
- Saffer D., Morley J•, Bill P.
- Sandler M., Glover V., Ashford A., Esmail A.
- Sarai K., Frazer A., Brunswick D, Mendels J.
- A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.
- J. Clin. Invest., 1976, 57, 791−796.
- Tricyclic antidepressant cardiotoxicity. Jama, 1976, 236, 18,2089−2090.1.ipramine toxicity.
- J. Urol., 1975, 114, Ш 3, 402−403.1.teractions of chlorpromazine and imipramine with, artificial membranes investigated by equilibrium dialysis, dualwavelength photometry and fluorimetry. Biochem. Pharmacol., 1979, 28, 6, 799−805.
- The effect of imipramine and lithium on a and B-receptor binding. Brain Res. in rat brain, 1979, 160, № 1, 186−191 .
- Potential danger of monoamineoxidase inhibitors and a-methyldopa. Lancet, 1963, (27 april), 950−951.
- Pressor effects of adrenergic agents and serotonin after administration of imipramine.
- Arzneimittel-Forsch., 1960, Bd.10,935−936.
- Carbohydrate metabolism on motor neurone desease.
- J. Neurol., Neurosurg. and Psychiat., 1977, 40, Jf> 6, 533−537.
- The inhibition of tyramine oxidation and the tyramine hypertensive response ('cheese effect») may be independent phenomena. J. Neural Transm., 1980, 48, 4, 241−247.
- Desmethylimipramine-induced decrease in B-adrenergic receptor binding in rat cerebral cortex.
- Biochem. Pharmacol., 1978, 27, $ 17, 2179−2181.
- Satchell D., Freeman Sh. Hopkinssondra V.218. Saton Т., Iwawoto T.
- Effects of a-methylnoradrenaline on cardiac metabolism.
- Biochem. Pharmacol., 1971, 20, 7, 1691' 1694.
- Neurotropic drugs, electroshock and carbohydrate metabolism in the rat. Biochem. Pharmacol., 1966, 15, 323−331.
- Sattin A., Stone Т., Taylor D.
- Schaeffer L., Chenoveth M., Dunn A.221. Schou M.222. Schrire J.
- Schweitzer J, Schwartz R., Friedhoff A.224. Segawa Т., Mizuta T.225. Shader R., DiMascio k.226. Sherlock S, 227. Sherman A.228. Shopsin B.
- Shopsin В., Stern S., Gershon S.
- Shu-Hui Kuo, Joseph K. Kamake. Rert K. Lum.
- Biochemical and electropharmaceutical studies with tricyclic antоdepressants in rat and guinea-pig cerebral cortex. Life Sci., 1978, 23, В 26, 2621−2626.
- Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.
- Biochem. Biophys. Acta, 1969, 192, 29 2−309.
- Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type.
- Acta Psychiat. Scand., 1962, 38, 331−336.
- Collapse after «Parstelin».
- Brit. Med. J., 1.963, (21 sept), 748.1.tact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine.
- J. Ueurochem., 1979, 33, 1, 377−379.
- Effect of imipramine on central 5-hydroxy-tryptamine turnover and metabolism in rats, Jap. J. Pharmacol., 1980, 30, 6, 789−793.
- Psychotropic Drug Side Effects. Williams E. Wilkins, Baltimore, Md., 1970.
- Deseases of the liver and biliary system. 4 th ed., Oxford Univ. Press, London and I.Y., 1968.
- Time course of the effects of antidepressants on serotonin rat neocortex. Commun. Psychopharm., 1979, 3, № 1, 1−5.
- Tricyclics and MAO inhibitors: rational polypharmacy in treatment-resistant depressions.
- Ueuro-Psychopharmacol.Proc. 10 th Congr. Coll. Int. Quebec, 1976, 2, Oxford, 1978, 1067−1083.
- Altered carbohydrate metabolism during treatment with lithium carbonate. Arch. Gen. Psychiat., 1972, 26, 566−571.
- Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlacticaci-nemia produced by sympathomimetic amines in the cat.
- Pharmacol. Exp. Ther., 1977, 202, $ 2, 301−309.231 232 233 234 235у23 б237 238 239 240 241 248
- Smith P., Porte D., Robertson R.1. Sigg E.
- Sigg E., Osborne Ivl#, Korol B.1. Speclor S.1. Sulman P., Winnik H.1. Sulser P., Dingell J.
- Sutherland E. Oye W., Butcher R.
- Sutherland E. Robison G., Butcher R.
- Traficante L. Sakalis G., Siekierski J.
- Tuck J, Siwers В., Hamberger B.
- Udenfriend S. Weissbach H., Bogdanski D.
- U’Prichard D. Greenberg D., Sheehan P., Snyder S.
- Neural regulation of the endocrine pancreas.
- Endocrine pancreas and diabetes, ed. Pierluissi J., Excerta Medica, Amsterdam, 1979.
- Pharmacological studies with Tofranil. Canad. Psychiat, Ass. J., 1959, 4, suppl, 75−83.
- Cardiovascular effects of imipramine, J. Pharmacol. Exp. Ther., 1963, 141, 237−243.
- Monoamine oxidase in control of brain serotonin and norepinephrine content. Ann. N.Y. Acad. Sci., 1963, 107, 856−864.
- Hormonal effects of chlorpromazine. Lancet, 1956, (21 jan), 161−162.
- On the role of adrenergic mechanisms in the mode of action of tricyclic antidepressants.
- Antidepressant drugs of non-MAO inhibitor type, ed. Etron D., Kety S., NJMH, Bethesda, Md, 1966, 1−19.
- The action of epinephrine and the role of the adenyl cyclase system in hormone actions.
- Recent Progr. Hormone Res., 1965, 21,623.
- Some aspects of the biological role of adenosine 3'5'-AMP. Circulation, 1968, 37, 279.
- Rapid in vitro sulfoxidation of chlorpromazine by human blood: inhibition by an endogenous plasma protein factor. Life Sci., 1979, 24, is 4, 337−346.
- Effects of clinical concentrations of tricyclic antidepressants on neuronal 5 HT neuron.
- Agents and Actions, 1975, 5, 505−509.
- Biochemical findings relating to the action of serotonin. Ann. itf.Y. Acad. Sci., 1957, 66, $ 3, 602−608.
- Tricyclic antidepressants: therapeutic properties and affinity for a-noradre-nergic receptor binding sites in the brain.
- Science, 1978, 199, JM325, 197−198.
- Virtanen R. Jisalo E., Irjala K.
- Von Velde C, Gordon M., Conn N.245* Vetulani J. Stawarz R., Dingell J.
- Waldmeier P., Baumann P., Greengrass P. Maitre L.247. Weiss B.248. Whybrow P.249. V/ollemann M, 250. Wold J., 1. ngnecker D, Fischer L.251. Woods S., Porte J.
- Ymviler A. Geller E., Eiduson S.
- Zeller E., Barsxy J., Berman E.
- Protein binding of doxepin and desme-thyl doxepin.
- Acta Pharmacol, et Toxicol., 1981, 49, suppl 1, 77.
- Manic-depressive illness, diabetesmellitus and lithium carbonate.
- Arch. Gen. Psychiat., 1969, 21, 478−485.
- A possible common mechanism of action of antidepressant treatments. Reduction in the sensitivity of the noradrenergic cyclic МНР generating system in the rat limbic forebrain.
- Naunyn-Schmiedebergs Arch. Pharmacol., 1976, 293, В 2, 109−114.
- Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover. Postgrad. Med. J., 1976,52, suppl, Is 3, 33−39.
- Psychotropic drags and cyclic nucleotide metabolism.
- Psychopharmacol. Bull., 1979, 15, № 4, 67−68.
- Tricyclic drugs and the hypothalamic-pituitary-thyroid axis. Lancet, 1980, В 8176, 1037.
- A biogen aminok receptorai.
- Magy. tudakad. biol. tud. oszt. kozl., 1978 (1979), 21, JS 23, 175−199.
- Species dependent pancreatic islet toxicity produced by cyproheptadine: alterations in beta cell structure and function.
- Toxicol. Appl. Pharmacol., 1971, 19, 188−201.
- Neural control of the endocrine pancreas. Physiol. Rev., 1974, 54, 596
- Effect of pyridoxine deficiency on in-ducibility and circadian rhythms of some pyridoxine-dependent enzymes. Biochim. Biophys. Acta., 1971, 244, 557−566.1. Amine oxidases.
- J. Biol. Chem., 1955, 214, 267−274.254. ZorU., 1. Mishkinsky J. Sulman F.255. Zor U., 1. cker D., Schleider M. Sulman F.
- She hypoglycaemic effect of mebanazine (actomol) and its mechanism. Biochem. Pharmacol., 1965, 14, 10 591 064.
- Metabolic and enzymatic effects on monoamine oxidase inhibitors with and without hydrocortisone on the accessory sex gland of the rat. Eur. J. Pharmacol., 1968, 3, 81−83.